Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06550401 · ClinicalTrials.gov registry record · NA

A Study of the BREAST-Q REACT Tool for People Having Breast Surgery

A NA study of Breast-conserving Surgery and Mastectomy With Reconstruction, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
NA
Development phase
69
Enrollment target
6
Study locations

NCT06550401: Active NA study of Breast-conserving Surgery and Mastectomy With Reconstruction, sponsored by Memorial Sloan Kettering Cancer Center.

NCT06550401 is a NA study of Breast-conserving Surgery and Mastectomy With Reconstruction that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 69 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 6 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06550401, a NA study of Breast-conserving Surgery and Mastectomy With Reconstruction, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
69 participants
Enrollment target
6
Study locations

Study Summary

The researchers are doing this study to find out whether it is practical (feasible) to conduct a larger study looking at the effects of the BREAST-Q Real-time Engagement and Communication Tool (REACT) on people's quality of life, interactions with their doctors, and medical interventions after undergoing routine breast conserving surgery or mastectomy. The BREAST-Q REACT tool shows scores from standard questionnaires completed before and after breast surgery about overall physical wellbeing, arm pain or tightness, the ability to move the arms and perform everyday tasks, and any symptoms related to the arms, and provides feedback including recommendations and detailed information that help explain these scores and guide topics for people and their doctor to discuss.

Primary Outcome

assessed by frequency data from initial eligibility screening to enrollment

Interventions

  • OTHER BREAST-Q Physical Well-Being
  • OTHER QuickDASH

Study Locations (6)

New York

  • Memorial Sloan Kettering Commack (All Protocol Activities) - Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities) - Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
  • Memorial Sloan Kettering Nassau (All Protocol Activities) - Uniondale

New Jersey

  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities) - Basking Ridge
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) - Middletown

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2024-08-09
Est. Completion 2026-08
Phase NA
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the registry record for NCT06550401 still lists

NCT06550401 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 69 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 2 conditions, with Breast-conserving Surgery appearing as the primary indexed condition, and to 2 interventions - of which BREAST-Q Physical Well-Being is the first listed.

NCT06550401 lists 6 locations in 2 states (New York, New Jersey).

Frequently Asked Questions

What is clinical trial NCT06550401 about?

NCT06550401 is a clinical study titled "A Study of the BREAST-Q REACT Tool for People Having Breast Surgery". The researchers are doing this study to find out whether it is practical (feasible) to conduct a larger study looking at the effects of the BREAST-Q Real-time Engagement and Communication Tool (REACT) on people's quality of life, interactions with their doctors, and medical interventions after under...

What is the current status of trial NCT06550401?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 69 participants. The study started on 2024-08-09. Estimated completion is 2026-08.

What conditions does trial NCT06550401 study?

This clinical trial studies the following conditions: Breast-conserving Surgery, Mastectomy With Reconstruction.

What interventions are being tested in trial NCT06550401?

The interventions under investigation include: BREAST-Q Physical Well-Being (OTHER), QuickDASH (OTHER).

Who is sponsoring clinical trial NCT06550401?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06550401 being conducted?

This trial has 6 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast-conserving Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06550401's enrollment target sits among peer trials

69 1133rd of 2000 higher than 868 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04020575 · 69 participants · Phase 1

    Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)

  • NCT04163614 · 69 participants · NA

    Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients

  • NCT04164641 · 69 participants · NA

    Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration

  • NCT04493372 · 69 participants · NA

    Deciphering Preserved Autonomic Function After Spinal Cord Injury

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06550401, the US trial registry maintained by the National Library of Medicine. NCT06550401 (small enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.